TRCT
SEM

Tower Research Capital (TRC)’s Select Medical SEM Stock Holding History

Tower Research Capital (TRC)’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Sell
8,133
-203
-2% -$3.35K ﹤0.01% 1975
2026
Q1 		$136K Buy
8,336
+2,013
+32% +$31.5K ﹤0.01% 1937
2025
Q4 		$93.9K Sell
6,323
-1,860
-23% -$26.3K ﹤0.01% 1988
2025
Q3 		$105K Sell
8,183
-3,456
-30% -$46.1K ﹤0.01% 1948
2025
Q2 		$177K Buy
11,639
+8,596
+282% +$134K ﹤0.01% 1897
2025
Q1 		$50.8K Sell
3,043
-9,508
-76% -$175K ﹤0.01% 2223
2024
Q4 		$237K Buy
12,551
+3,785
+43% +$73K ﹤0.01% 1602
2024
Q3 		$165K Sell
8,766
-30,793
-78% -$590K ﹤0.01% 1797
2024
Q2 		$747K Buy
39,559
+37,219
+1,591% +$635K 0.01% 998
2024
Q1 		$38K Sell
2,340
-55,528
-96% -$813K ﹤0.01% 2464
2023
Q4 		$733K Buy
57,868
+36,654
+173% +$463K 0.01% 1072
2023
Q3 		$289K Buy
21,214
+17,725
+508% +$274K 0.01% 1209
2023
Q2 		$59.9K Sell
3,489
-1,181
-25% -$18.3K ﹤0.01% 2452
2023
Q1 		$65K Buy
4,670
+3,467
+288% +$51K ﹤0.01% 2272
2022
Q4 		$17K Sell
1,203
-13,105
-92% -$169K ﹤0.01% 3289
2022
Q3 		$170K Buy
14,308
+5,841
+69% +$83K ﹤0.01% 2080
2022
Q2 		$108K Buy
8,467
+6,091
+256% +$78.2K ﹤0.01% 2227
2022
Q1 		$31K Buy
2,376
+76
+3% +$1K ﹤0.01% 3121
2021
Q4 		$36K Sell
2,300
-14,543
-86% -$248K ﹤0.01% 3053
2021
Q3 		$328K Buy
16,843
+7,457
+79% +$148K 0.01% 1304
2021
Q2 		$214K Sell
9,386
-47,179
-83% -$979K 0.01% 1877
2021
Q1 		$1.04M Buy
56,565
+32,244
+133% +$529K 0.02% 767
2020
Q4 		$362K Sell
24,321
-152,261
-86% -$1.99M 0.01% 1252
2020
Q3 		$1.98M Buy
176,582
+149,880
+561% +$1.48M 0.02% 401
2020
Q2 		$212K Buy
+26,702
New +$221K 0.01% 1743
2020
Q1 		– Sell
-4,337
Closed -$55K – 3799
2019
Q4 		$55K Buy
+4,337
New +$46.7K ﹤0.01% 1281
2019
Q3 		– Sell
-7,693
Closed -$66K – 4474
2019
Q2 		$66K Buy
+7,693
New +$60.8K ﹤0.01% 1421
2018
Q2 		– Sell
-854
Closed -$8K – 4015
2018
Q1 		$8K Sell
854
-32,159
-97% -$306K ﹤0.01% 2563
2017
Q4 		$314K Sell
33,013
-2,637
-7% -$25.2K 0.04% 424
2017
Q3 		$368K Buy
35,650
+35,548
+34,851% +$328K 0.03% 380
2017
Q2 		$1K Buy
+102
New +$765 ﹤0.01% 2516
2017
Q1 		– Sell
-3,267
Closed -$23K – 3818
2016
Q4 		$23K Buy
+3,267
New +$22.7K ﹤0.01% 2020
2016
Q3 		– Sell
-7,018
Closed -$41K – 4348
2016
Q2 		$41K Buy
7,018
+6,814
+3,340% +$45.1K ﹤0.01% 1703
2016
Q1 		$1K Buy
+204
New +$1.09K ﹤0.01% 3767
2015
Q3 		– Sell
-15,852
Closed -$138K – 4667
2015
Q2 		$138K Buy
15,852
+13,666
+625% +$115K 0.01% 578
2015
Q1 		$17K Sell
2,186
-11,996
-85% -$89.6K ﹤0.01% 2385
2014
Q4 		$110K Buy
14,182
+6,606
+87% +$48.2K 0.01% 557
2014
Q3 		$49K Sell
7,576
-56,588
-88% -$437K 0.01% 1547
2014
Q2 		$539K Buy
64,164
+63,294
+7,275% +$491K 0.07% 237
2014
Q1 		$6K Sell
870
-7,103
-89% -$43.1K ﹤0.01% 3126
2013
Q4 		$50K Buy
7,973
+7,231
+975% +$35.3K 0.01% 1399
2013
Q3 		$3K Sell
742
-2,406
-76% -$11K ﹤0.01% 3965
2013
Q2 		$14K Buy
+3,148
New +$13.9K ﹤0.01% 2058

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Tower Research Capital (TRC)'s SEM Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Select Medical (SEM) stake by 2.4% in Q2 2026, selling an estimated $3.35K and leaving 8,133 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

Tower Research Capital (TRC) first reported a position in SEM in Q2 2013 and has held it in 43 quarters since. The position peaked at $1.98M in Q3 2020. 239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Tower Research Capital (TRC) held 8,133 shares of Select Medical worth $134K as of Q2 2026.
  • Tower Research Capital (TRC) sold 203 Select Medical shares in Q2 2026, an estimated $3.35K.
  • Select Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #1975 holding.
  • Tower Research Capital (TRC) first reported a position in Select Medical in Q2 2013 and has held it in 43 quarters since.
  • Tower Research Capital (TRC)'s Select Medical position peaked at $1.98M in Q3 2020.
  • 239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.